http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 09 Jun 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html <p>ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, &quot;Without getting under your skin: non-invasive stimulation activates the vagus nerve,&quot; has been accepted for publication in <em>Frontiers in Neuroscience</em>.</p> <p>Authored by Norianne Theresa Ingram, PhD; Colin Daniels, MD, MBA; Nina Riggins, MD, PhD; Jennifer R. Stevane, MD, FACS; and Peter S. Staats, MD, MBA; the article synthesizes decades of scientific evidence supporting the ability of cervical non-invasive vagus nerve stimulation (nVNS) to activate vagal pathways without surgical implantation.</p> <p>The review evaluates http://www.streetinsider.com/Press+Releases/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html Tue, 09 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html <p>ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, &quot;Without getting under your skin: non-invasive stimulation activates the vagus nerve,&quot; has been accepted for publication in <em>Frontiers in Neuroscience</em>.</p> <p>Authored by Norianne Theresa Ingram, PhD; Colin Daniels, MD, MBA; Nina Riggins, MD, PhD; Jennifer R. Stevane, MD, FACS; and Peter S. Staats, MD, MBA; the article synthesizes decades of scientific evidence supporting the ability of cervical non-invasive vagus nerve stimulation (nVNS) to activate vagal pathways without surgical implantation.</p> <p>The review evaluates http://www.streetinsider.com/Press+Releases/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html Tue, 09 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html <p>ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, &quot;Without getting under your skin: non-invasive stimulation activates the vagus nerve,&quot; has been accepted for publication in <em>Frontiers in Neuroscience</em>.</p> <p>Authored by Norianne Theresa Ingram, PhD; Colin Daniels, MD, MBA; Nina Riggins, MD, PhD; Jennifer R. Stevane, MD, FACS; and Peter S. Staats, MD, MBA; the article synthesizes decades of scientific evidence supporting the ability of cervical non-invasive vagus nerve stimulation (nVNS) to activate vagal pathways without surgical implantation.</p> <p>The review evaluates http://www.streetinsider.com/Press+Releases/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html Tue, 09 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html <p>ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, &quot;Without getting under your skin: non-invasive stimulation activates the vagus nerve,&quot; has been accepted for publication in <em>Frontiers in Neuroscience</em>.</p> <p>Authored by Norianne Theresa Ingram, PhD; Colin Daniels, MD, MBA; Nina Riggins, MD, PhD; Jennifer R. Stevane, MD, FACS; and Peter S. Staats, MD, MBA; the article synthesizes decades of scientific evidence supporting the ability of cervical non-invasive vagus nerve stimulation (nVNS) to activate vagal pathways without surgical implantation.</p> <p>The review evaluates http://www.streetinsider.com/Globe+Newswire/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html Tue, 09 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html <p>ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, &quot;Without getting under your skin: non-invasive stimulation activates the vagus nerve,&quot; has been accepted for publication in <em>Frontiers in Neuroscience</em>.</p> <p>Authored by Norianne Theresa Ingram, PhD; Colin Daniels, MD, MBA; Nina Riggins, MD, PhD; Jennifer R. Stevane, MD, FACS; and Peter S. Staats, MD, MBA; the article synthesizes decades of scientific evidence supporting the ability of cervical non-invasive vagus nerve stimulation (nVNS) to activate vagal pathways without surgical implantation.</p> <p>The review evaluates http://www.streetinsider.com/Globe+Newswire/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html Tue, 09 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html <p>ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, &quot;Without getting under your skin: non-invasive stimulation activates the vagus nerve,&quot; has been accepted for publication in <em>Frontiers in Neuroscience</em>.</p> <p>Authored by Norianne Theresa Ingram, PhD; Colin Daniels, MD, MBA; Nina Riggins, MD, PhD; Jennifer R. Stevane, MD, FACS; and Peter S. Staats, MD, MBA; the article synthesizes decades of scientific evidence supporting the ability of cervical non-invasive vagus nerve stimulation (nVNS) to activate vagal pathways without surgical implantation.</p> <p>The review evaluates http://www.streetinsider.com/Globe+Newswire/Frontiers+in+Neuroscience+Accepts+Review+Article+Synthesizing+Evidence+that+Cervical+nVNS+Activates+the+Vagus+Nerve+Without+Surgery/26620399.html Tue, 09 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html <p>ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=08MrtQLPsWyilQqy4g1aHTo_2bhFwlm1YvDRSZ07J86t24_c4jVKI3S4fmOSlOk5yRJPqojy8k5-7WcCZpEDantSzHLMWdYtcF7rA7PoA-iCCGeWzLCTNkAjOoneASgB" rel="nofollow" target="_blank">electroCore, Inc.</a> (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort &amp; Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.</p> <p><strong>Planet MicroCap Las Vegas 2026 Powered by MicroCapClub Details:</strong></p> <p>Dates: June 17 - 18, 2026<br/>Company Presentation: Wednesday, June 17 at 10:30 am PT<br/>Location: Bellagio Resort &amp; Casino, Las http://www.streetinsider.com/Press+Releases/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html Tue, 02 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html <p>ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=08MrtQLPsWyilQqy4g1aHTo_2bhFwlm1YvDRSZ07J86t24_c4jVKI3S4fmOSlOk5yRJPqojy8k5-7WcCZpEDantSzHLMWdYtcF7rA7PoA-iCCGeWzLCTNkAjOoneASgB" rel="nofollow" target="_blank">electroCore, Inc.</a> (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort &amp; Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.</p> <p><strong>Planet MicroCap Las Vegas 2026 Powered by MicroCapClub Details:</strong></p> <p>Dates: June 17 - 18, 2026<br/>Company Presentation: Wednesday, June 17 at 10:30 am PT<br/>Location: Bellagio Resort &amp; Casino, Las http://www.streetinsider.com/Press+Releases/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html Tue, 02 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html <p>ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=08MrtQLPsWyilQqy4g1aHTo_2bhFwlm1YvDRSZ07J86t24_c4jVKI3S4fmOSlOk5yRJPqojy8k5-7WcCZpEDantSzHLMWdYtcF7rA7PoA-iCCGeWzLCTNkAjOoneASgB" rel="nofollow" target="_blank">electroCore, Inc.</a> (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort &amp; Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.</p> <p><strong>Planet MicroCap Las Vegas 2026 Powered by MicroCapClub Details:</strong></p> <p>Dates: June 17 - 18, 2026<br/>Company Presentation: Wednesday, June 17 at 10:30 am PT<br/>Location: Bellagio Resort &amp; Casino, Las http://www.streetinsider.com/Press+Releases/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html Tue, 02 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html <p>ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=08MrtQLPsWyilQqy4g1aHTo_2bhFwlm1YvDRSZ07J86t24_c4jVKI3S4fmOSlOk5yRJPqojy8k5-7WcCZpEDantSzHLMWdYtcF7rA7PoA-iCCGeWzLCTNkAjOoneASgB" rel="nofollow" target="_blank">electroCore, Inc.</a> (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort &amp; Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.</p> <p><strong>Planet MicroCap Las Vegas 2026 Powered by MicroCapClub Details:</strong></p> <p>Dates: June 17 - 18, 2026<br/>Company Presentation: Wednesday, June 17 at 10:30 am PT<br/>Location: Bellagio Resort &amp; Casino, Las http://www.streetinsider.com/Globe+Newswire/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html Tue, 02 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html <p>ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=08MrtQLPsWyilQqy4g1aHTo_2bhFwlm1YvDRSZ07J86t24_c4jVKI3S4fmOSlOk5yRJPqojy8k5-7WcCZpEDantSzHLMWdYtcF7rA7PoA-iCCGeWzLCTNkAjOoneASgB" rel="nofollow" target="_blank">electroCore, Inc.</a> (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort &amp; Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.</p> <p><strong>Planet MicroCap Las Vegas 2026 Powered by MicroCapClub Details:</strong></p> <p>Dates: June 17 - 18, 2026<br/>Company Presentation: Wednesday, June 17 at 10:30 am PT<br/>Location: Bellagio Resort &amp; Casino, Las http://www.streetinsider.com/Globe+Newswire/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html Tue, 02 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html <p>ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=08MrtQLPsWyilQqy4g1aHTo_2bhFwlm1YvDRSZ07J86t24_c4jVKI3S4fmOSlOk5yRJPqojy8k5-7WcCZpEDantSzHLMWdYtcF7rA7PoA-iCCGeWzLCTNkAjOoneASgB" rel="nofollow" target="_blank">electroCore, Inc.</a> (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort &amp; Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.</p> <p><strong>Planet MicroCap Las Vegas 2026 Powered by MicroCapClub Details:</strong></p> <p>Dates: June 17 - 18, 2026<br/>Company Presentation: Wednesday, June 17 at 10:30 am PT<br/>Location: Bellagio Resort &amp; Casino, Las http://www.streetinsider.com/Globe+Newswire/electroCore+to+Present+at+the+Planet+MicroCap+Las+Vegas+2026+Powered+by+MicroCapClub/26587761.html Tue, 02 Jun 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+28++Filed+by%3A+Lev+Joshua+S./26575032.html si-local-file:///var/storage/secattach/20260529/26575032.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+28++Filed+by%3A+Lev+Joshua+S./26575032.html Fri, 29 May 2026 16:06:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+28++Filed+by%3A+Lev+Joshua+S./26575032.html si-local-file:///var/storage/secattach/20260529/26575032.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+28++Filed+by%3A+Lev+Joshua+S./26575032.html Fri, 29 May 2026 16:06:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+20++Filed+by%3A+Errico+Thomas+J./26546629.html si-local-file:///var/storage/secattach/20260526/26546629.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+20++Filed+by%3A+Errico+Thomas+J./26546629.html Tue, 26 May 2026 08:52:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+20++Filed+by%3A+Errico+Thomas+J./26546629.html si-local-file:///var/storage/secattach/20260526/26546629.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+20++Filed+by%3A+Errico+Thomas+J./26546629.html Tue, 26 May 2026 08:52:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+22++Filed+by%3A+Lev+Joshua+S./26543133.html si-local-file:///var/storage/secattach/20260522/26543133.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+22++Filed+by%3A+Lev+Joshua+S./26543133.html Fri, 22 May 2026 18:11:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+22++Filed+by%3A+Lev+Joshua+S./26543133.html si-local-file:///var/storage/secattach/20260522/26543133.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+May+22++Filed+by%3A+Lev+Joshua+S./26543133.html Fri, 22 May 2026 18:11:00 -0400 ECOR O.07507914 http://www.streetinsider.com/Corporate+News/electroCore+study+shows+Quell+device+reduces+fibromyalgia+pain/26482050.html <p>electroCore Inc. (NASDAQ: ECOR) announced publication of clinical trial results in JAMA Network Open showing its Quell electrical nerve stimulation device reduced movement-related pain when combined with physical therapy for fibromyalgia patients.</p><p>The cluster randomized clinical trial enrolled 384 participants with fibromyalgia, with 191 receiving physical therapy plus Quell treatment and 193 receiving physical therapy alone. At day 60, the physical therapy-Quell group showed significantly greater reduction in movement-evoked pain compared to the physical therapy-only group, with a between-group difference of -1.2 points and a P-value of less than 0.001.</p><p>The study found statistically significant improvements favoring the combined treatment group across http://www.streetinsider.com/Corporate+News/electroCore+study+shows+Quell+device+reduces+fibromyalgia+pain/26482050.html Wed, 13 May 2026 08:00:55 -0400 ECOR http://www.streetinsider.com/FDA/electroCore+study+shows+Quell+device+reduces+fibromyalgia+pain/26482050.html <p>electroCore Inc. (NASDAQ: ECOR) announced publication of clinical trial results in JAMA Network Open showing its Quell electrical nerve stimulation device reduced movement-related pain when combined with physical therapy for fibromyalgia patients.</p><p>The cluster randomized clinical trial enrolled 384 participants with fibromyalgia, with 191 receiving physical therapy plus Quell treatment and 193 receiving physical therapy alone. At day 60, the physical therapy-Quell group showed significantly greater reduction in movement-evoked pain compared to the physical therapy-only group, with a between-group difference of -1.2 points and a P-value of less than 0.001.</p><p>The study found statistically significant improvements favoring the combined treatment group across http://www.streetinsider.com/FDA/electroCore+study+shows+Quell+device+reduces+fibromyalgia+pain/26482050.html Wed, 13 May 2026 08:00:55 -0400 ECOR http://www.streetinsider.com/Press+Releases/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html <p>ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in <em>JAMA Network Open</em> titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.”</p> <p>The study evaluated the use of a modified Quell device, an FDA-authorized nonpharmacological wearable stimulation device, when added to outpatient physical therapy (“PT”) for people with fibromyalgia. The trial enrolled 384 participants [that completed baseline data collection], including 191 individuals in the PT-Quell group and 193 individuals in the PT-only http://www.streetinsider.com/Press+Releases/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html Wed, 13 May 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html <p>ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in <em>JAMA Network Open</em> titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.”</p> <p>The study evaluated the use of a modified Quell device, an FDA-authorized nonpharmacological wearable stimulation device, when added to outpatient physical therapy (“PT”) for people with fibromyalgia. The trial enrolled 384 participants [that completed baseline data collection], including 191 individuals in the PT-Quell group and 193 individuals in the PT-only http://www.streetinsider.com/Press+Releases/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html Wed, 13 May 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html <p>ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in <em>JAMA Network Open</em> titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.”</p> <p>The study evaluated the use of a modified Quell device, an FDA-authorized nonpharmacological wearable stimulation device, when added to outpatient physical therapy (“PT”) for people with fibromyalgia. The trial enrolled 384 participants [that completed baseline data collection], including 191 individuals in the PT-Quell group and 193 individuals in the PT-only http://www.streetinsider.com/Press+Releases/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html Wed, 13 May 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html <p>ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in <em>JAMA Network Open</em> titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.”</p> <p>The study evaluated the use of a modified Quell device, an FDA-authorized nonpharmacological wearable stimulation device, when added to outpatient physical therapy (“PT”) for people with fibromyalgia. The trial enrolled 384 participants [that completed baseline data collection], including 191 individuals in the PT-Quell group and 193 individuals in the PT-only http://www.streetinsider.com/Globe+Newswire/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html Wed, 13 May 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html <p>ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in <em>JAMA Network Open</em> titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.”</p> <p>The study evaluated the use of a modified Quell device, an FDA-authorized nonpharmacological wearable stimulation device, when added to outpatient physical therapy (“PT”) for people with fibromyalgia. The trial enrolled 384 participants [that completed baseline data collection], including 191 individuals in the PT-Quell group and 193 individuals in the PT-only http://www.streetinsider.com/Globe+Newswire/electroCore+Announces+Publication+in+JAMA+Highlighting+the+Benefits+of+Adding+Quell+Electrical+Nerve+Stimulation+to+Outpatient+Physical+Therapy+in+Fibromyalgia/26481929.html Wed, 13 May 2026 08:00:00 -0400 A.15536158 ECOR O.07507914